Nanologica AB
Nanologica AB (publ), a nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science industry in China, India, the United State of America, and internationally. It offers NLAB Saga, a new generation silica for preparative chromatography; and SVEA, a pre-packaged columns for analytical chromatography; and high-performance liquid chromatography, a separatio… Read more
Nanologica AB (NICA) - Total Liabilities
Latest total liabilities as of December 2025: Skr65.47 Million SEK
Based on the latest financial reports, Nanologica AB (NICA) has total liabilities worth Skr65.47 Million SEK as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Nanologica AB - Total Liabilities Trend (2012–2025)
This chart illustrates how Nanologica AB's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Nanologica AB Competitors by Total Liabilities
The table below lists competitors of Nanologica AB ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Atlas Technology Grp
PINK:ATYG
|
USA | $397.75K |
|
P2 Solar Inc
PINK:PTOS
|
USA | $1.16 Million |
|
Precomp Solutions AB Series B
ST:PCOM-B
|
Sweden | Skr72.30 Million |
|
Nickel Creek Platinum Corp
OTCQB:NCPCF
|
USA | $819.42K |
|
DOLLAR GENERAL
MU:7DG
|
Germany | €24.55 Billion |
|
Vanity Capital Inc
V:VYC-H
|
Canada | CA$8.29K |
|
District Mines Ltd
V:DIG-H
|
Canada | CA$1.49 Million |
Liability Composition Analysis (2012–2025)
This chart breaks down Nanologica AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.85 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.89 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.74 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Nanologica AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Nanologica AB (2012–2025)
The table below shows the annual total liabilities of Nanologica AB from 2012 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Skr65.47 Million | -5.10% |
| 2024-12-31 | Skr68.99 Million | -13.03% |
| 2023-12-31 | Skr79.33 Million | -2.49% |
| 2022-12-31 | Skr81.36 Million | +74.13% |
| 2021-12-31 | Skr46.72 Million | -12.48% |
| 2020-12-31 | Skr53.38 Million | +39.87% |
| 2019-12-31 | Skr38.16 Million | +259.34% |
| 2018-12-31 | Skr10.62 Million | -55.70% |
| 2017-12-31 | Skr23.98 Million | +143.71% |
| 2016-12-31 | Skr9.84 Million | +14.02% |
| 2015-12-31 | Skr8.63 Million | -24.54% |
| 2014-12-31 | Skr11.43 Million | +252.85% |
| 2013-12-31 | Skr3.24 Million | +20.11% |
| 2012-12-31 | Skr2.70 Million | -- |